A phase II study to evaluate how safe and effective the study drug abatacept (injected subcutaneously) is compared to placebo in treating diffuse cutaneous systemic sclerosis A phase II study to evaluate how safe and effective the study drug abatacept(injected subcutaneously ...
A phase II study to evaluate subcutaneous abatacept vs. placebo in diffuse cutaneous systemic sclerosis—a double-blind, placebo-controlled, randomized controlled trial - The Abatacept Systemic SclErosis Trial (ASSET) A phase II study to evaluate subcutaneous abataceptvs. placebo in diffuse cutaneous systemic scleros ...
A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial. A Phase 2 Study to Evaluate Subcutaneous Abataceptvs. Placebo in Diffuse Cutaneous Systemic Sclerosi ...
A Study to Evaluate the Safety and Efficacy of Abatacept in Patients With Diffuse Systemic Sclerosis (Scleroderma) A Study to Evaluate the Safety and Efficacy of Abataceptin Patients With Diffuse Systemic Sclerosis ...
A Pilot Study to Evaluate the Safety and Efficacy of Abatacept in Patients With Systemic Sclerosis